HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...

BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) ...

Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of MASLD.

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

Tariffs, though designed as economic tools, have ripple effects that extend deeply into the regulatory framework of the ...

Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to GE HealthCare's Aurora nuclear medicine system and ...

Zimmer Biomet has adjusted its 2025 earnings forecast to $7.90-$8.10 per share, down from previous estimates falling between ...

Firefly Neuroscience has completed the acquisition of Evoke Neuroscience, a developer of technologies aimed at assessing ...

InBrain Neuroelectronics has won a €4m ($4.5m) grant from the Spanish Ministry of Industry and Tourism to develop its BCI ...

URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM ...